Treatment Details – 12.4 months
|Patients: This study involved forty-nine patients with malignant pleural mesothelioma. There were 10 women and 39 men, with a median age of 59 years, ranging from 28 to 81.|
Some had previously been treated with chemotherapy drugs such as pemetrexed, cisplatin, gemcitabine, carboplatin, and doxorubicin.
Treatment: Patients were treated with surgery, extrapleural pneumonectomy.
Toxicity: Complications from surgery included atrial fibrillation, laryngeal nerve palsy, temporary paraplegia, and stroke.
Results: The median overall survival was 12.4 months (376 days).
Correspondence: Dr. Walter Klepetko